Loading...

Bavarian Nordic A/S

BVNRYPNK
Healthcare
Biotechnology
$12.26
$-0.18(-1.42%)

Bavarian Nordic A/S (BVNRY) Stock Overview

Explore Bavarian Nordic A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.0/100

Key Financials

Market Cap2.9B
P/E Ratio14.52
EPS (TTM)$0.87
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Week$9.44
1 Month$9.02
3 Months$11.84
1 Year Target$7.24

BVNRY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bavarian Nordic A/S (BVNRY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 65.89, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $7.24.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.52 and a market capitalization of 2.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;